Table 3.5

Surveillance After Renal or Mesenteric Artery Revascularization

IndicationAppropriate Use Score (1–9)
Asymptomatic
55.
  • Baseline surveillance (within 1 month) after revascularization

A (8)
New or Worsening Symptoms After Baseline
56.
  • After renal or mesenteric artery revascularization

A (8)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency During First YearAt 3 to 5 monthsAt 6 to 8 monthsAt 9 to 12 months
57.
  • During first 12 months after endovascular revascularization

I (3)U (6)U (6)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency After First YearEvery 6 monthsEvery 12 monthsEvery 24 months or greater
58.
  • After first 12 months after endovascular revascularization

I (3)A (7)U (5)

A = appropriate; I = inappropriate; U = uncertain.